Citigroup’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1,000K | Sell |
|
|||||
|
2025
Q1 | $3.16M | Buy |
|
|||||
|
2024
Q4 | $2.39M | Buy |
|
|||||
|
2024
Q3 | $806K | Buy |
|
|||||
|
2024
Q2 | $370K | Sell |
|
|||||
|
2024
Q1 | $3.91M | Buy |
|
|||||
|
2023
Q4 | $1.91M | Sell |
|
|||||
|
2023
Q3 | $2.98M | Buy |
|
|||||
|
2023
Q2 | $4.08M | Sell |
|
|||||
|
2023
Q1 | $8.14M | Buy |
|
|||||
|
2022
Q4 | $3.05M | Sell |
|
|||||
|
2022
Q3 | $4.71M | Buy |
|
|||||
|
2022
Q2 | $3.32M | Buy |
|
|||||
|
2022
Q1 | $770K | Sell |
|
|||||
|
2021
Q4 | $4.48M | Sell |
|
|||||
|
2021
Q3 | $5.72M | Buy |
|
|||||
|
2021
Q2 | $3.07M | Buy |
|
|||||
|
2021
Q1 | $3.12M | Buy |
|
|||||
|
2020
Q4 | $326K | Buy |
|
|||||
|
2020
Q3 | $85K | Sell |
|
|||||
|
2020
Q2 | $650K | Sell |
|
|||||
|
2020
Q1 | $507K | Buy |
|
|||||
|
2019
Q4 | $218K | Sell |
|
|||||
|
2019
Q3 | $1.48M | Buy |
|
|||||
|
2019
Q2 | $2.11M | Buy |
|
|||||
|
2019
Q1 | $546K | Sell |
|
|||||
|
2018
Q4 | $1.89M | Buy |
|
|||||
|
2018
Q3 | $711K | Buy |
|
|||||
|
2018
Q2 | $562K | Buy |
|
|||||
|
2018
Q1 | $129K | Sell |
|
|||||
|
2017
Q4 | $822K | Buy |
|
|||||
|
2017
Q3 | $464K | Sell |
|
|||||
|
2017
Q2 | $500K | Buy |
|
|||||
|
2017
Q1 | $383K | Sell |
|
|||||
|
2016
Q4 | $2.01M | Buy |
|
|||||
|
2016
Q3 | $382K | Buy |
|
|||||
|
2016
Q2 | $131K | Sell |
|
|||||
|
2016
Q1 | $427K | Buy |
|
|||||
|
2015
Q4 | $63K | Sell |
|
|||||
|
2015
Q3 | $425K | Buy |
|
|||||
|
2015
Q2 | $149K | Sell |
|
|||||
|
2015
Q1 | $119K | Sell |
|
|||||
|
2014
Q4 | $113K | Buy |
|
|||||
|
2014
Q3 | $7K | Buy |
|
|||||
|
2014
Q2 | $4K | Sell |
|
|||||
|
2014
Q1 | $43K | Buy |
|